I've held tentative optimism about the Autolus Therapeutics plc ( AUTL ) investment thesis for some time now, despite the market and company-specific risks posed by bringing another CD19 cell therapy to market. Indeed, theI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pit ...